m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00620
|
[1], [2], [3] | |||
: m6A sites
Indirect
Enhancement
RNA modification
MYCN
MYCN
ALYREF
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 14 (METTL14) | WRITER | |||
| m6A Target | hsa-miR-34a | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> 5-methylcytidine (m5C) | ||||
| Epigenetic Regulator | THO complex subunit 4 (ALYREF) | READER | View Details | ||
| Regulated Target | N-myc proto-oncogene protein (MYCN) | View Details | |||
| Crosstalk Relationship | m6A → m5C | Enhancement | |||
| Crosstalk Mechanism | m6A modification indirectly impacts RNA modification through downstream signaling pathways | ||||
| Crosstalk Summary | METTL14 interacts with hsa-miR-34a, reading its m6A level and promoting its physical interaction with N-myc proto-oncogene protein (MYCN), which was regulated by ALYREF-mediated m5C modification. | ||||
In-vitro Model |
Kelly | Neuroblastoma | Homo sapiens | CVCL_2092 | |
| SK-N-BE(2)-C | Neuroblastoma | Homo sapiens | CVCL_0529 | ||
References
: m6A sites
: modification sites